<DOC>
	<DOCNO>NCT01906164</DOCNO>
	<brief_summary>This study ass safety , tolerability , pharmacokinetics ( PK ) orally administer ALS-008176 healthy volunteer .</brief_summary>
	<brief_title>Study Single Multiple Doses ALS-008176 Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Respiratory Syncytial Virus Infections</mesh_term>
	<criteria>Male female subject , 1855 year age , good health screen laboratory value within limit specify protocol Body mass index 1830 kg/m2 Female subject must nonchildbearing potential ; male subject must surgically sterile practice birth control Clinically significant uncontrolled medical illness Use , anticipate use conduct study , concomitant medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>RSV</keyword>
</DOC>